Q3 2026 results · 30 October 2026

One drug, Dupixent, brought in €5.7bn, nearly 40% of Sanofi's sales.

€5.7Bsales of Dupixent, up 34.8% at CER

€14.4Bsales, up 14.3% at CER

€1.4Bfrom new launches, up 31.4% at CER

Source

Get a note when Sanofi reports next.

Whatco sends a short notification with the number that matters, and the full story of the company is a tap away.